Sign in

CIK 0001100682

  • Large accelerated filer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Sign in to watch
Ticker
CRL
Exchange
NYSE
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 27
Entity type
Operating
EIN
061397316
Phone
+1 781-222-6000
Business address
251 BALLARDVALE ST, WILMINGTON, MA, 01887
Former names
CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
  1. 4 Shares withheld for taxes Corporate Executive VP & CFO gave up 331 shares (to pay taxes)
  2. 4 Shares withheld for taxes CEVP, Disc & Safety Assessment gave up 213 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, Corp Strategy & Develop gave up 366 shares (to pay taxes)
  4. 4 Shares withheld for taxes CSVP&Chief Accounting Officer gave up 112 shares (to pay taxes)
  5. 4 Shares withheld for taxes Corporate Executive VP & COO gave up 640 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP & Chief People Officer gave up 276 shares (to pay taxes)
  7. 4 Grant or award Director acquired 946 shares (grant or award)
  8. 4 Grant or award Director acquired 1,465 shares (grant or award)
  9. 4 Grant or award Director acquired 1,761 shares (grant or award)
  10. 4 Grant or award Director acquired 1,576 shares (grant or award)
  11. 4 Grant or award Director acquired 946 shares (grant or award)
  12. 4 Grant or award Director acquired 946 shares (grant or award)
  13. 4 Planned sale Director sold 140 shares at an average $137.57 ($19,260)
  14. 4 Planned sale Director sold 140 shares at an average $140.74 ($19,703)
  15. 4 Open-market sale EVP, Corp Strategy & Develop sold 500 shares at $145.41 ($72,705)
  16. 4 Shares withheld for taxes Corporate Executive VP & CFO gave up 889 shares (to pay taxes)
  17. 4 Gift Corporate Executive VP & COO gave 430 shares (gift)
  18. 4 Open-market buy Chairman, President and CEO bought 6,075 shares at $165.01 ($1,002,436)
  19. 4 Open-market buy Corporate Executive VP & COO bought 1,514 shares at $164.63 ($249,250)
  20. 4 Open-market sale EVP, Corp Strategy & Develop sold 4,400 shares at $162.50 ($715,000)

Page 5 of 84 · 1,663 filings